Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 14, 2022. The report discloses a material change in corporate leadership regarding the appointment of an Interim Chief Financial Officer.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on executive appointments and does not contain financial performance data.
Material Changes
- Executive Appointment: The Board of Directors appointed Peter Ludlum as Interim Chief Financial Officer, effective April 18, 2022.
- Role Scope: Mr. Ludlum will serve as the Company's principal accounting officer and principal financial officer until a successor is chosen or until earlier resignation/removal.
- Compensation Structure: Mr. Ludlum will provide services as an independent contractor and employee of Danforth Advisors, LLC. Danforth will receive cash compensation at a rate of $400 per hour for Mr. Ludlum's services.
- Contract Terms: The underlying Consulting Agreement (dated November 30, 2021) may be terminated with cause immediately or without cause upon 30 days' prior written notice.
Outlook, Risks, and Management Commentary
The filing contains no forward-looking guidance, risk factors, or management commentary regarding the company's operational outlook. The appointment is intended to ensure continuity in financial leadership. Mr. Ludlum brings 17 years of C-level executive experience, including prior roles as CFO at Emmaus Life Sciences, Inc. and Energy and Power Solutions, Inc.
Key Facts for Investor Verification
- Verify the effective date of the Interim CFO appointment (April 18, 2022).
- Confirm the hourly compensation rate of $400 paid to Danforth Advisors, LLC for Mr. Ludlum's services.
- Review the full Consulting Agreement filed as Exhibit 10.1 for complete termination clauses and obligations.
- Note that Mr. Ludlum has no family relationship with current directors or officers and no reportable transactions under Item 404(a) of Regulation S-K.